Wal-Mart Expands $4 Generic Drugs to 11 More States

November 17, 2006

Wal-Mart Stores Inc. is expanding its $4 generic prescription program to 11 additional states and adding 17 more prescriptions to the program.

The world’s largest retailer added 502 stores to those offering the discounted medications. The new states added Thursday were Idaho, Kentucky, Maine, Massachusetts, Nebraska, Oklahoma, Rhode Island, South Carolina, Utah, Washington and West Virginia. In all, Wal-Mart is offering the program in 3,009 stores in 38 states.

The $4 price is for up to a 30-day supply of the drugs, which will now number 331. That number counts some drugs more than once if they are sold in a variety of dosages or solid and liquid forms.

The company began the program in September, offering the low-cost drugs in Florida and had plans to expand the offering in January. But the company said it moved up its timetable.

Wal-Mart launched the program in what it called an effort to save working Americans money on health care. Critics said it was a stunt to draw in business and a grab for a bigger share of the drug business.

Wal-Mart said it intends to continue to push for expansion to other states as quickly as possible.

Was this article valuable?

Here are more articles you may enjoy.

Latest Comments

  • November 30, 2006 at 1:42 am
    Henry the eighth I am says:
    All stores will be wal-mart. Britney Spears will launch her 4th comeback tour just days after her 7th divorce. The Federal Government will do something right.
  • November 20, 2006 at 1:42 am
    wudchuck says:
    well, it\'s not the matter of $$$...in reality, i think we finally have made it known to the drug manufacturers, they are getting out of hand for cost of drugs...when drugs ar... read more
  • November 17, 2006 at 3:23 am
    Druggie says:
    \"Wal-Mart launched the program in what it called an effort to save working Americans money on health care. Critics said it was a stunt to draw in business and a grab for a bi... read more

Add a CommentSee All Comments (3)Add a Comment

Your email address will not be published. Required fields are marked *

*

More News
More News Features